Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II Menno V. Huisman,

Slides:

Advertisements

Similar presentations

Use of Propensity Scores to Assess Comparability of Treatment Groups in a Registry Program 1 Kenneth J Rothman On behalf of Menno V Huisman, Gregory Y.H.

Advertisements

1 Objectives, design and initial results from Phase I Nils Schoof Corp. Dept. Global Epidemiology, Boehringer Ingelheim GmbH.

Results of the 1 st Phase of the International GLORIA-AF Registry Program: Regional Treatment Differences Before the Era of Novel Anticoagulants MV Huisman,

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

An Unusual Electrocardiogram in a Heart Transplant Recipient Hamish I. MacLachlan, BSc, MBBS, Jonathan R. Dalzell, MD, MRCP The American Journal of Medicine.

An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist.

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Severe Tuberculosis Sepsis in an Immunocompetent Patient

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO

New-onset Atrial Fibrillation Predicts Heart Failure Progression

Bleeding Toes in Diabetic Neuropathy

Pierre Loulergue, MD, MSc, Agnès Guerre, MD

Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study Torben Bjerregaard Larsen, MD,

An Unusual Cause of Leg Ulcerations

Characteristics of Hospitalized Patients with Atrial Fibrillation in Taiwan: A Nationwide Observation Cheng-Han Lee, MD, Ping-Yen Liu, MD, PhD, Liang-Miin.

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study Torben Bjerregaard Larsen, MD,

Bleeding Toes in Diabetic Neuropathy

Pierre Loulergue, MD, MSc, Agnès Guerre, MD

Tim McAlindon, MD, MPH, Margaret Formica, MSPH, Christopher H

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials Giulia Renda, MD, PhD, Marta.

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation Giulia Renda, MD, PhD, Marco.

SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation Pilar Gallego, MD, PhD, Vanessa Roldán,

‘Real-World’ Antithrombotic Treatment in Atrial Fibrillation: The EORP-AF Pilot Survey Gregory Y.H. Lip, MD, Cécile Laroche, MSc, Gheorghe-Andrei Dan,

Thomas E. MacMillan, MD, MSc, Terence Tang, MD, Rodrigo B

Epidemiology of Myelodysplastic Syndromes

Trend in Mortality after Stroke with Atrial Fibrillation

Robert Goulden, MBBS, MSc, MPhil, MA The American Journal of Medicine

Gregory Y.H. Lip, MD, Jonathan L. Halperin, MD, Hung-Fat Tse, MD, PhD

R. Graham Barr, MD, DrPH, Bartolome R. Celli, MD, Fernando J

Juice Plus or Toxicity Plus

The Reply The American Journal of Medicine

TIA for the Internist The American Journal of Medicine

History of Thyroid Disorders in Relation to Clinical Outcomes in Atrial Fibrillation Helene Bruere, MD, Laurent Fauchier, MD, PhD, Anne Bernard Brunet,

Gout in African Americans

The natural history of post-traumatic hypopituitarism: Implications for assessment and treatment Amar Agha, MD, Jack Phillips, MD, Patrick O’Kelly, MSc,

Carlos Aguilar, MD, Valentin del Villar, MD

Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin Keitaro Senoo, MD, Marco Proietti,

Isla M. Ogilvie, PhD, Nick Newton, PhD, Sharon A

External Validation of the Simple NULL-PLEASE Clinical Score in Predicting Outcome of Out-of-Hospital Cardiac Arrest Tatjana S. Potpara, MD, PhD, Miroslav.

The Reply The American Journal of Medicine

Does Methylphenidate Reduce the Symptoms of Chronic Fatigue Syndrome?

Disseminated Zoster After Trauma in an Immunocompetent Patient

Geographic Tongue The American Journal of Medicine

Sharan Prakash Sharma, MD, Karleung Siu, MD

To Reduce Stroke with PFO Closure, Respect the Shunt

Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey Maura Marcucci, MD, Gregory Y.H. Lip,

Effect of Folic Acid, with or without Other B Vitamins, on Cognitive Decline: Meta- Analysis of Randomized Trials David S. Wald, MA, MRCP, MD, Anuradhani.

John-Michael Gamble, BScPharm, MSc, Dean T. Eurich, PhD, Thomas J

One-way Versus Two-way Text Messaging on Improving Medication Adherence: Meta- analysis of Randomized Trials David S. Wald, MD, FRCP, Shahena Butt, MSc,

Yoko Miyasaka, MD, PhD, Marion E. Barnes, MSc, Bernard J

Purple Urinary Bag Syndrome

National Trends in Ambulatory Oral Anticoagulant Use

A Post-cure Complication

Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and the Risk of Major Bleeding in Patients with Nonvalvular Atrial Fibrillation

Sister Mary Joseph's Node

The American Journal of Medicine

Plasma Lactescence in Acute Pancreatitis

Combining Antiplatelet and Antithrombotic Therapy (Triple Therapy): What Are the Risks and Benefits? Luis Alejandro Asencio, MD, Jennifer J. Huang, DO,

Screening and Treatment of Vitamin D Deficiency on Hospital Admission: Is There a Benefit for Medical Inpatients? Lena Grädel, MD, Meret Merker, BMSc,

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation Giulia Renda, MD, PhD, Marco.

Diagnosing Bilateral Tarsal Tunnel Syndrome

Falls in Older Adults: Risk Assessment, Management and Prevention

Emily G. McDonald, MD, MSc, Ramy R. Saleh, MD, Todd C. Lee, MD, MPH

Toward a More Responsible News Media

David Tian, MD, Ram Jhingan Mohan, MD, Gary Stallings, MD

Preoperative Thienopyridine Use and Outcomes after Surgery: A Systematic Review Anita G. Au, MD, Sumit R. Majumdar, MD MPH, Finlay A. McAlister, MD MSc

Hypophosphatemia: Diagnostic Significance in Legionnaires’ Disease

Presentation transcript:

Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II Menno V. Huisman, MD, Kenneth J. Rothman, DrPH, Miney Paquette, MSc, Christine Teutsch, MD, Hans Christoph Diener, MD, Sergio J. Dubner, MD, Jonathan L. Halperin, MD, Changsheng Ma, MD, Kristina Zint, MD, Amelie Elsaesser, MD, Dorothee B. Bartels, MD, Gregory Y.H. Lip, MD The American Journal of Medicine Volume 128, Issue 12, Pages 1306-1313.e1 (December 2015) DOI: 10.1016/j.amjmed.2015.07.013 Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 1 Definition of geographical regions and country participation in GLORIA-AF. The American Journal of Medicine 2015 128, 1306-1313.e1DOI: (10.1016/j.amjmed.2015.07.013) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 2 Atrial fibrillation types and symptom categories (all regions). The American Journal of Medicine 2015 128, 1306-1313.e1DOI: (10.1016/j.amjmed.2015.07.013) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 3 Antithrombotic treatment at baseline overall and by stroke risk (all regions). ASA = acetylsalicylic acid; VKA = vitamin K antagonists. The American Journal of Medicine 2015 128, 1306-1313.e1DOI: (10.1016/j.amjmed.2015.07.013) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 4 Antithrombotic treatment at baseline by region. ASA = acetylsalicylic acid; VKA = vitamin K antagonists. The American Journal of Medicine 2015 128, 1306-1313.e1DOI: (10.1016/j.amjmed.2015.07.013) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 5 Antithrombotic treatment at baseline by stroke risk and region. The American Journal of Medicine 2015 128, 1306-1313.e1DOI: (10.1016/j.amjmed.2015.07.013) Copyright © 2015 Elsevier Inc. Terms and Conditions